Home » Topics » Regulatory

Regulatory
RSS

FDA approves Heplisav-B for prevention of hepatitis B in adults

Nov. 10, 2017

FDA approves Adcetris in new indication

Nov. 10, 2017

FDA approves Prevymis for CMV prevention in adult HSCT recipients

Nov. 9, 2017

FDA approves Keryx's Auryxia in new indication

Nov. 8, 2017

Nicox announces FDA approval of Vyzulta, recaps pipeline progress

Nov. 3, 2017

Calquence approved and available to order in U.S. for mantle cell lymphoma

Nov. 2, 2017

Ebola vaccine approved in China

Oct. 26, 2017

FDA approves CAR T therapy Yescarta for adults with relapsed or refractory large B-cell lymphoma

Oct. 19, 2017

Health Canada first to approve Shingrix

Oct. 16, 2017

SKYZoster approved in South Korea

Oct. 16, 2017